SMFM Statement: clarification of recommendations regarding cell-free DNA aneuploidy screening.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 26458766.
- Also identified by DOI 10.1016/j.ajog.2015.09.077.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this statement is to clarify that the Society for Maternal-Fetal Medicine (SMFM) does not recommend that cell-free DNA aneuploidy screening be offered to all pregnant women, nor does it suggest a requirement for insurance coverage for cell-free DNA screening in women at low risk of aneuploidy. However, SMFM believes, due to the ethics of patient autonomy, that the option should be available to women who request additional testing beyond what is currently recommended by professional societies.
Medical subject headings
- Aneuploidy
- DNA
- Prenatal Diagnosis